Axon Therapies
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $32M
Investors
- 5
About Axon Therapies
Axon Therapies, Inc. specializes in innovative medical solutions targeting heart failure patients, specifically those with preserved ejection fraction (HFpEF), through advanced catheter technology. Founded in 2014 in New York, US, Axon Therapies, Inc. focuses on developing solutions for heart failure management. The company's leadership includes Zoar Engelman as the founder and Chad Hoskins as the CEO. In September 2025, Axon Therapies, Inc. Axon Therapies focuses on innovative medical solutions for patients suffering from heart failure, particularly those with preserved ejection fraction (HFpEF). Their primary product, the Axon Ablation Catheter, offers a novel implant-free procedure that targets the right greater splanchnic nerve through the femoral vein. The device utilizes targeted ablation therapy to interrupt nerve signals, thereby reducing sympathetic activity and aiding in the normalization of fluid balance within the body. The procedure is designed to be minimally invasive, typically completed in under an hour, and is intended for outpatient settings.The revenue model for Axon Therapies is centered around partnerships with healthcare facilities and cardiologists who adopt their flagship product, the Axon Ablation Catheter. These transactions occur directly between Axon Therapies and medical institutions, where the catheter is procured for use in outpatient procedures. The company potentially engages in B2B transactions, providing training and support services to ensure proper use of the device. Pricing structures for their products are designed to reflect the novel nature and effectiveness of the treatment, which emphasizes patient outcomes and procedural efficiency. As a result, revenue is generated through the sale of the ablation catheter and associated support services, establishing a sustainable business model within the cardiology sector.
Who invested in Axon Therapies
5 investors across 1 round
See all investors in Axon Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 25, 2025
Amount
$32M
Investors
Questions about Axon Therapies
Who invested in Axon Therapies?
Axon Therapies has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axon Therapies raised?
Axon Therapies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Axon Therapies last raise money?
Axon Therapies's most recent round on record is a Series A, in Sep 2025.
What does Axon Therapies do?
Axon Therapies is a medical devices & equipment company.
Where is Axon Therapies headquartered?
Axon Therapies is headquartered in New York, US.
Which VCs invest in companies like Axon Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Axon Therapies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Axon Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.